
GC17904
Leflunomide
Also known as 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
Leflunomide (HWA486) is a pyrimidine biosynthesis inhibitor that acts by inhibiting dihydroorotate dehydrogenase (DHODH) and has anti-rheumatic effects
ChemicalCAS75706-12-6MW270.21FormulaC12H9F3N2O2
- CAS number
- 75706-12-6
- Molecular weight
- 270.21
- Formula
- C12H9F3N2O2
- Solubility
- ≥ 83·3mg/mL in DMSO
- InChIKey
- VHOGYURTWQBHIL-UHFFFAOYSA-N
- Catalogue number
- GC17904
- Brand
- GLPBIO
Computed properties PubChem CID 3899 · XLogP 2.5 · TPSA 55.1 Ų · H-bond donors 1
- XLogP
- 2.5
- TPSA
- 55.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 2
- Heavy atoms
- 19
SMILES CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
Computed descriptors from PubChem (CID 3899), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il